U.S. Healthcare Services Stock News

NYSE:ALB
NYSE:ALBChemicals

Is Albemarle (ALB) Pricing Fair After Strong Yearly Surge And DCF Upside Signals

Many investors are considering whether Albemarle's current share price fairly reflects its potential, or if the stock might be mispriced. The stock recently closed at US$177.47, with a 4.3% gain over the past 7 days, a decline of 11.1% over the past 30 days, and returns of 23.3% year to date and 211.1% over the last year. Recent headlines around Albemarle have kept attention on the stock, and investors are closely watching how broader sentiment toward materials and battery related companies...
NasdaqGS:LRCX
NasdaqGS:LRCXSemiconductor

Lam Research Weighs AI Chip Upside Against Rich Valuation And Insider Sales

Lam Research (NasdaqGS:LRCX) is in focus as AI driven demand for advanced chips supports multiyear capacity expansion plans at major memory producers. Micron has outlined a multiyear, multibillion dollar investment program, signaling sustained equipment needs that could directly involve suppliers like Lam Research. This reflects a broader industry shift toward higher AI related chip output, which is expected to influence Lam Research's order pipeline over several years. Lam Research enters...
NasdaqGS:APP
NasdaqGS:APPSoftware

Meta Exit Gives AppLovin AXON More Room In iOS Ad Auctions

Meta Platforms is reported to have pulled back from bidding on key non-IDFA iOS mobile ad inventory. This change directly affects a core segment of AppLovin's AXON AI ad platform business. The shift gives AppLovin (NasdaqGS:APP) more room to compete for this traffic without head-to-head bidding from Meta. AppLovin runs a large mobile advertising and app monetization platform, with AXON AI focused on matching ads to users across iOS and other ecosystems. With a major competitor stepping back...
NYSE:CCK
NYSE:CCKPackaging

How Analyst Concerns Over Input Costs And Scale At Crown Holdings (CCK) Have Changed Its Investment Story

Recently, analyst outlet StockStory flagged Crown Holdings as a stock to avoid, citing limited growth potential, slower earnings progress than peers, and pressure on gross margins from elevated input costs. The critique also argues that Crown’s large scale could actually constrain its flexibility, potentially giving smaller packaging rivals a competitive edge in capturing growth. We’ll now examine how concerns about high input costs and margin pressure may alter Crown Holdings’ existing...
NasdaqGS:IREN
NasdaqGS:IRENSoftware

Why IREN (IREN) Is Up 28.7% After $1.6 Billion Nvidia AI Infrastructure Deal - And What's Next

Earlier this week, IREN announced a roughly US$1.60 billion deal to buy Nvidia Blackwell systems from Dell Technologies to equip its Childress, Texas data centers and fulfill a previously disclosed five-year, US$3.40 billion AI cloud services agreement. This large-scale GPU purchase underscores IREN’s accelerated move away from Bitcoin mining toward operating as an AI infrastructure provider with contracted cloud revenue. We’ll now examine how this US$1.60 billion Blackwell investment...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

How Investors May Respond To Royalty Pharma (RPRX) Strong Q1 Royalties And Expanding Biotech Partnerships

Royalty Pharma recently reported strong first-quarter 2026 results, highlighting double-digit growth in portfolio and royalty receipts and continued expansion of its more than 35 marketed therapies and 20 development-stage assets. At the same time, the company has been drawing increased investor interest as a major buyer of biopharmaceutical royalties, using collaborations in areas such as oncology, rare disease and neuroscience to reinforce confidence in its long-term cash flow...
NasdaqGS:FAST
NasdaqGS:FASTTrade Distributors

A Look At Fastenal (FAST) Valuation After Revenue Meets Expectations But EBITDA Misses

Fastenal (FAST) just reported quarterly revenue in line with expectations, but a miss on EBITDA estimates prompted a 10.8% share price drop. This has put the focus squarely on how the company is balancing growth and profitability. See our latest analysis for Fastenal. That EBITDA miss came after a strong run, with the share price still up 10.83% year to date and a 5 year total shareholder return of 92.79%. However, recent 3 month momentum has faded slightly. If this earnings move has you...
NasdaqGS:KHC
NasdaqGS:KHCFood

Is JELL-O Simply’s Clean-Label Shift Quietly Recasting Kraft Heinz’s Brand Narrative (KHC)?

Earlier this month, Kraft Heinz’s JELL-O brand launched JELL-O Simply, a permanent line of gelatin and pudding desserts made with real fruit juice, no FD&C colors or artificial sweeteners, and less sugar in ready-to-eat products, alongside a limited-time KD Mac & Cheesecake dessert in Canada and upcoming investor participation at Deutsche Bank’s Global Consumer Conference. These moves highlight Kraft Heinz’s push to refresh iconic brands with simpler ingredient profiles and playful line...
NYSE:MOD
NYSE:MODBuilding

Modine Manufacturing (MOD) Margin Drop To 3.4% Tests Bullish Growth Narratives

Modine Manufacturing (MOD) just closed out FY 2026 with Q4 revenue of US$954.4 million and basic EPS of US$1.36, alongside trailing 12 month revenue of US$3.2 billion and EPS of US$2.26. These results reflect a year shaped by both solid quarterly profits and a large one off loss. Over recent periods, the company has seen quarterly revenue move from US$647.2 million with EPS of US$0.92 in FY 2025 Q4 to FY 2026 quarterly figures ranging between US$682.8 million and US$954.4 million. Over the...
OTCPK:MDRX
OTCPK:MDRXHealthcare Services

Veradigm (MDRX) Loss Of US$291.5 Million Tests Bullish Turnaround Narratives

Veradigm (MDRX) has just put fresh numbers on the table for FY 2024, with trailing 12 month revenue of US$594.4 million and a reported loss of US$291.5 million, alongside basic EPS of US$2.7 in the red. This sets a clear backdrop of revenue scale paired with negative earnings. The company has seen trailing revenue hold in a tight band between US$588.0 million and US$625.9 million over recent periods, while net income swung from a profit of US$49.2 million to a loss of US$291.5 million. This...
NYSE:MSI
NYSE:MSICommunications

Is Motorola Solutions (MSI) Pricing In Too Much Optimism After Recent Public Safety Focus?

For investors assessing whether Motorola Solutions at US$408.71 represents a solid opportunity or is already pricing in a lot of optimism, this article walks through what the numbers indicate about value. The stock is up 3.2% over the past week, down 5.3% over the past month, up 7.3% year to date, and its return over the past year declined 1.8%, while the 3 year and 5 year returns sit at 49.8% and 108.9% respectively. Recent attention on Motorola Solutions has focused on its role in mission...
NYSE:DOCN
NYSE:DOCNIT

DigitalOcean AI Use In Hippocratic Healthcare Milestone Meets Rich Valuation

Hippocratic AI has reached 10 million patient calls on DigitalOcean’s AI-Native Cloud, in collaboration with NVIDIA. The milestone comes from production use in healthcare, a sector that relies on high reliability and safety. The partnership gives DigitalOcean Holdings (NYSE:DOCN) direct exposure to real world AI workloads beyond test or pilot projects. For investors tracking NYSE:DOCN, this healthcare milestone sits at the intersection of cloud infrastructure and applied AI. DigitalOcean is...
NYSE:LMT
NYSE:LMTAerospace & Defense

A Look At Lockheed Martin (LMT) Valuation As It Expands US$9b Missile Defense Capacity

Lockheed Martin (LMT) has just broken ground on a new 87,000 square foot Munitions Production Center in Troy, Alabama, as part of a multi year investment of more than US$9 billion to expand missile defense output. See our latest analysis for Lockheed Martin. Recent contract wins in Canada and with the U.S. Navy, alongside the Alabama munitions expansion and upcoming Bernstein conference appearance, sit against a share price of US$531.14. Short term returns have been softer after a 90 day...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

How Investors Are Reacting To Veracyte (VCYT) ASCO Phase III Data And New Oncology Launch Plans

Veracyte recently highlighted phase III clinical data for its Prosigna Breast and Decipher Prostate tests at the 2026 ASCO Annual Meeting, underscoring their use in guiding chemotherapy decisions. This latest clinical evidence, alongside expectations for multiple new product launches within 18 months, reinforces Veracyte’s effort to broaden its diagnostics portfolio and address new oncology markets. Next, we’ll examine how the phase III ASCO data for Prosigna and Decipher might reshape...
NasdaqGS:DOX
NasdaqGS:DOXIT

Amdocs (DOX) Margin Stability Faces Scrutiny As EPS Softens In Q2 2026

Amdocs (DOX) Q2 2026 earnings: steady top line, softer EPS, and a margins story investors will focus on Amdocs (DOX) has reported Q2 2026 revenue of US$1,172 million and basic EPS of US$1.29, with the stock trading around US$61.29 as investors weigh the latest set of numbers. The company has seen quarterly revenue move from US$1,110 million in Q1 2025 to US$1,172 million in Q2 2026, while basic EPS has ranged from US$1.34 to US$1.46 in early 2025 to US$1.29 this quarter, setting a clear track...
NYSE:AGL
NYSE:AGLHealthcare

Does agilon health’s (AGL) Flat Near-Term Sales Outlook Undermine Its Value-Based Care Investment Story?

Recently, agilon health was reported to be facing underwhelming customer growth, ongoing cash burn and a projected flat sales outlook for the next 12 months, intensifying scrutiny of its value-based care platform for seniors. An important implication is that doubts about the long-term viability of agilon health's business model are growing just as it aims to transform Medicare-focused primary care. We’ll now explore how concerns about flat near-term sales could influence agilon health’s...
NYSE:AMTM
NYSE:AMTMProfessional Services

A Look At Amentum Holdings (AMTM) Valuation After Q1 EPS Miss And Recent Share Price Pullback

Amentum Holdings (AMTM) is back on investors’ radar after its recent Q1 earnings, where revenue aligned with expectations but EPS fell short, and the stock has declined since that update. At the same time, the company has created a new Chief AI Architect role, appointing Dr. Sam Nazari to lead Amentum-wide AI integration across defense, intelligence, energy, space, and commercial clients. See our latest analysis for Amentum Holdings. The Q1 EPS miss appears to have reset expectations. The...
NYSE:S
NYSE:SSoftware

AWS Security Hub Integration Might Change The Case For Investing In SentinelOne (S)

In May 2026, Amazon Web Services announced that SentinelOne’s Singularity Platform became available through AWS Security Hub Extended, enabling console-native, pay-as-you-go deployment of its AI-powered endpoint and cloud workload protection across all commercial AWS regions. This integration reduces procurement friction by letting enterprises use existing AWS budgets and contracts to add SentinelOne’s autonomous security, potentially broadening its reach among AWS-centric customers. Next,...
NYSE:BXMT
NYSE:BXMTMortgage REITs

How Issuing 6.250% Senior Notes To Refinance Debt At Blackstone Mortgage Trust (BXMT) Has Changed Its Investment Story

Blackstone Mortgage Trust, Inc. has completed a private offering of US$450,000,000 of 6.250% senior secured notes due 2031, with semi-annual interest payments beginning December 1, 2026 and the flexibility for early redemption under specified conditions. The company plans to use the net proceeds for general corporate purposes, including paying down existing secured indebtedness, which could reshape its funding mix and interest expense profile over the coming years. We’ll now examine how...
NYSE:PBF
NYSE:PBFOil and Gas

Assessing PBF Energy (PBF) Valuation After US$500 Million Senior Notes Refinancing

PBF Energy (PBF) has drawn fresh attention after its subsidiaries completed a US$500 million senior notes offering due 2034. The proceeds will primarily be used to redeem existing 6.00% senior notes maturing in 2028. See our latest analysis for PBF Energy. The refinancing news comes after a sharp pullback, with the stock down 4.85% on a 1-day share price basis and 10.52% over 7 days. At the same time, the year-to-date share price return of 34.10% and 1-year total shareholder return of 94.51%...
NYSE:YSG
NYSE:YSGPersonal Products

Yatsen Holding (NYSE:YSG) Q1 Loss Restart Challenges Bullish Profitability Narrative

Yatsen Holding (NYSE:YSG) opened 2026 with Q1 revenue of C¥1.0b and a basic EPS loss of C¥0.64, alongside trailing 12 month revenue of C¥4.5b and a trailing EPS loss of C¥1.45. Over the past reported quarters, revenue has ranged from C¥833.5m in Q1 2025 to C¥1.4b in Q4 2025, while quarterly basic EPS has moved between a loss of C¥3.98 and a profit of C¥0.09. This gives investors a clear view of how top line scale and per share results have shifted through the last year. With that backdrop,...
NasdaqGS:GTX
NasdaqGS:GTXAuto Components

Assessing Garrett Motion (GTX) Valuation After Strong Results Outlook Hike And Faster Capital Returns

Garrett Motion (GTX) is back in focus after strong quarterly results, a higher 2025 outlook, faster capital returns through dividends and buybacks, and updates on next generation turbo and electric powertrain technologies. See our latest analysis for Garrett Motion. At a share price of $33.90, Garrett Motion has seen strong momentum, with a 30 day share price return of 61.35% and year to date share price return of 95.05%. The 1 year total shareholder return of 206.33% points to sustained...
NYSE:OII
NYSE:OIIEnergy Services

What Oceaneering International (OII)'s Egyptian Subsea Contract Win Means For Shareholders

Oceaneering International, Inc. recently announced that its Offshore Projects Group secured an integrated offshore installation contract at Egypt’s West Delta Deep Marine gas field from Burullus Gas Company, covering transportation, installation, and commissioning of a refurbished subsea umbilical and a 2,000-meter thermoplastic composite pipe flowline. The award, which builds on umbilical refurbishment work completed at Oceaneering’s Rosyth, UK facility and includes remotely operated...